Optimizing ambulatory reflux monitoring: current findings and future directions

References

• El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun;63(6):871–880. doi: 10.1136/gutjnl-2012-304269. PubMed PMID: 23853213; PubMed Central PMCID: PMCPMC4046948.
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Hemond C, Eisa M, et al. The changing epidemiology of gastroesophageal reflux disease: are patients getting younger? J Neurogastroenterol Motil. 2018 Oct 1;24(4): 559–569. doi: 10.5056/jnm18140. PubMed PMID: 30347935; PubMed Central PMCID: PMCPMC6175565.
   PubMed Web of Science ®Google Scholar
• Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022 Jan 1;117(1):27–56. doi: 10.14309/ajg.0000000000001538. PubMed PMID: 34807007; PubMed Central PMCID: PMCPMC8754510.
   PubMed Web of Science ®Google Scholar
• Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology. 2018 Jan;154(2):267–276. doi: 10.1053/j.gastro.2017.07.045. PubMed PMID: 28780072; PubMed Central PMCID: PMCPMC5797499.
   PubMed Web of Science ®Google Scholar
• Vaezi MF. Atypical manifestations of gastroesophageal reflux disease. MedGenmed. 2005 Oct 27;7(4):25. PubMed PMID: 16614647; PubMed Central PMCID: PMCPMC1681743.
   PubMedGoogle Scholar
• Delshad SD, Almario CV, Chey WD, et al. Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms. Gastroenterology. 2020 Apr;158(5):1250–1261.e2. doi: 10.1053/j.gastro.2019.12.014. PubMed PMID: 31866243; PubMed Central PMCID: PMCPMC7103516.
   PubMed Web of Science ®Google Scholar
• Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002 May;122(5):1500–1511. doi: 10.1053/gast.2002.32978. PubMed PMID: 11984534.
   PubMed Web of Science ®Google Scholar
• Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology. 2009 Mar;136(3):741–754. doi: 10.1053/j.gastro.2009.01.015. PubMed PMID: 19166855.
   PubMed Web of Science ®Google Scholar
• Francis DO, Rymer JA, Slaughter JC, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013 Jun;108(6):905–911. doi: 10.1038/ajg.2013.69. PubMed PMID: 23545710.
   PubMed Web of Science ®Google Scholar
• Patel D, Fass R, Vaezi M. Untangling nonerosive reflux disease from functional heartburn. Clin Gastroenterol Hepatol. 2020 Apr 1. doi: 10.1016/j.cgh.2020.03.057. PubMed PMID: 32246998.
   Web of Science ®Google Scholar
• Clarrett DM, Hachem C. Gastroesophageal Reflux Disease (GERD). Mo Med. 2018 May;115(3):214–218. PubMed PMID: 30228725; PubMed Central PMCID: PMCPMC6140167.
   PubMedGoogle Scholar
• Patel DA, Vaezi MF. Utility of esophageal mucosal impedance as a diagnostic test for esophageal disease. Curr Opin Gastroenterol. 2017 Jul;33(4):277–284. doi: 10.1097/MOG.0000000000000367. PubMed PMID: 28437259.
   PubMed Web of Science ®Google Scholar
• Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990 Jan 27;335(8683):205–208. doi: 10.1016/0140-6736(90)90287-F. PubMed PMID: 1967675.
   PubMed Web of Science ®Google Scholar
• Tefera L, Fein M, Ritter MP, et al. Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? Am Surg. 1997 Oct;63(10):933–936. PubMed PMID: 9322676
   PubMed Web of Science ®Google Scholar
• Johansson KE, Ask P, Boeryd B, et al. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1986 Sep;21(7):837–847. doi: 10.3109/00365528609011128. PubMed PMID: 3775250.
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a kalixanda study report. Scand J Gastroenterol. 2005 Mar;40(3):275–285. doi: 10.1080/00365520510011579. PubMed PMID: 15932168.
   PubMed Web of Science ®Google Scholar
• Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007 Feb;41(2):131–137. doi: 10.1097/01.mcg.0000225631.07039.6d. PubMed PMID: 17245209.
   PubMed Web of Science ®Google Scholar
• Klauser AG, Heinrich C, Schindlbeck NE, et al. Is long-term esophageal pH monitoring of clinical value? Am J Gastroenterol. 1989 Apr;84(4):362–366. PubMed PMID: 2929555.
   PubMed Web of Science ®Google Scholar
• Hershcovici T, Zimmerman J. Functional heartburn vs. non-erosive reflux disease: similarities and differences. Aliment Pharmacol Ther. 2008 Jun 1;27(11):1103–1109. doi: 10.1111/j.1365-2036.2008.03666.x. PubMed PMID: 18315589.
   PubMed Web of Science ®Google Scholar
• O’Hara J, Stocken DD, Watson GC, et al. Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial. BMJ. 2021 Jan 7;372:m4903. Available from: www.icmje.org/coi_disclosure.pdf
   PubMedGoogle Scholar
• Dent J, Vakil N, Jones R, Bytzer P, Schoning U, Halling K, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the diamond study. Gut. 2010 Jun;59(6):714–721. doi: 10.1136/gut.2009.200063. PubMed PMID: 20551454.
   PubMed Web of Science ®Google Scholar
• Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012 Sep;61(9):1340–1354. doi: 10.1136/gutjnl-2011-301897. PubMed PMID: 22684483.
   PubMed Web of Science ®Google Scholar
• Kleiman DA, Beninato T, Bosworth BP, et al. Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease. J Gastrointest Surg. 2014 Jan;18(1):26–34. discussion 33-4. doi: 10.1007/s11605-013-2327-x. PubMed PMID: 24214090.
   PubMed Web of Science ®Google Scholar
• Afaneh C, Zoghbi V, Finnerty BM, et al. BRAVO esophageal pH monitoring: more cost-effective than empiric medical therapy for suspected gastroesophageal reflux. Surg Endosc. 2016 Aug;30(8):3454–3460. doi: 10.1007/s00464-015-4629-4. PubMed PMID: 26537906.
   PubMed Web of Science ®Google Scholar
• American Gastroenterological Association medical position statement: guidelines on the use of esophageal pH recording. Gastroenterology. 1996 Jun;110(6):1981. doi:10.1053/gast.1996.1101981. PubMed PMID: 8964427.
   PubMed Web of Science ®Google Scholar
• Zhou LY, Wang Y, Lu JJ, et al. Accuracy of diagnosing gastroesophageal reflux disease by GerdQ, esophageal impedance monitoring and histology. J of Digest Dis. 2014 May;15(5):230–238. doi: 10.1111/1751-2980.12135. PubMed PMID: 24528678.
   PubMed Web of Science ®Google Scholar
• Scarpulla G, Camilleri S, Galante P, et al. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol. 2007 Dec;102(12):2642–2647. doi: 10.1111/j.1572-0241.2007.01461.x. PubMed PMID: 17850412.
   PubMed Web of Science ®Google Scholar
• Ates F, Yuksel ES, Higginbotham T, et al. Mucosal impedance discriminates GERD from non-GERD conditions. Gastroenterology. 2015 Feb;148(2):334–343. doi: 10.1053/j.gastro.2014.10.010. PubMed PMID: 25448923.
   PubMed Web of Science ®Google Scholar
• Patel DA, Higginbotham T, Slaughter JC, et al. Development and validation of a mucosal impedance contour analysis system to distinguish esophageal disorders. Gastroenterology. 2019 May;156(6):1617–1626.e1. PubMed PMID: 30711626. doi: 10.1053/j.gastro.2019.01.253
   PubMed Web of Science ®Google Scholar
• Kavitt RT, Higginbotham T, Slaughter JC, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol. 2012 Dec;107(12):1826–1832. doi: 10.1038/ajg.2012.342. PubMed PMID: 23090349.
   PubMed Web of Science ®Google Scholar
• Kline MM, Ewing M, Simpson N, et al. The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing. Clin Gastroenterol Hepatol. 2008 Aug;6(8):880–885. quiz 836. doi: 10.1016/j.cgh.2008.01.016. PubMed PMID: 18424190.
   PubMed Web of Science ®Google Scholar
• Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006 Sep;101(9):1956–1963. doi: 10.1111/j.1572-0241.2006.00711.x. PubMed PMID: 16848801.
   PubMed Web of Science ®Google Scholar
• Lawenko RM, Lee YY. Evaluation of Gastroesophageal Reflux Disease Using the Bravo Capsule pH System. J Neurogastroenterol Motil. 2015 Jan 31;22(1): 25–30. doi: 10.5056/jnm15151. PubMed PMID: 26717929; PubMed Central PMCID: PMCPMC4699719.
   Web of Science ®Google Scholar
• Iluyomade A, Olowoyeye A, Fadahunsi O, et al. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials. Dis Esophagus. 2016 Feb 1;30(3):1–9. doi: 10.1111/dote.12464. PubMed PMID: 26952638.
   Web of Science ®Google Scholar
• Patel D, Fass R, Vaezi M. Untangling nonerosive reflux disease from functional heartburn. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1314–1326. doi: 10.1016/j.cgh.2020.03.057. PubMed PMID: 32246998.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Gan T, Wang L, et al. Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: a multicenter clinical study. World J Gastroenterol. 2014 Oct 28;20(40):14865–14874. doi: 10.3748/wjg.v20.i40.14865. PubMed PMID: 25356046; PubMed Central PMCID: PMCPMC4209549.
   PubMed Web of Science ®Google Scholar
• Roman S, Bruley des Varannes S, Pouderoux P, et al. Ambulatory 24-h oesophageal impedance-pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil. 2006 Nov;18(11):978–986. doi: 10.1111/j.1365-2982.2006.00825.x. PubMed PMID: 17040408.
   PubMed Web of Science ®Google Scholar
• Zerbib F, Roman S, Bruley Des Varannes S, et al. Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility. Clin Gastroenterol Hepatol. 2013 Apr;11(4):366–372. doi: 10.1016/j.cgh.2012.10.041. PubMed PMID: 23142603.
   PubMed Web of Science ®Google Scholar
• Smits MJ, Loots CM, van Wijk MP, et al. An expert panel-based study on recognition of gastro-esophageal reflux in difficult esophageal pH-impedance tracings. Neurogastroenterol Motil. 2015 May;27(5):637–645. doi: 10.1111/nmo.12536. PubMed PMID: 25756933.
   PubMed Web of Science ®Google Scholar
• Sifrim D, Roman S, Savarino E, et al. Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world. Gut. 2021 Oct 9;70(8):1441–1449. doi: 10.1136/gutjnl-2020-322627. PubMed PMID: 33037054.
   Web of Science ®Google Scholar
• *Gyawali CP, Rogers B, Frazzoni M, et al. Inter-reviewer variability in interpretation of pH-Impedance studies: the wingate consensus. Clin Gastroenterol Hepatol. 2021 Sep;19(9):1976–1978.e1. doi: 10.1016/j.cgh.2020.09.002. PubMed PMID: 32890752. Variability in interpretation of impedance studies.
   PubMed Web of Science ®Google Scholar
• Frazzoni M, Savarino E, de Bortoli N, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol. 2016 Jan;14(1):40–46. doi: 10.1016/j.cgh.2015.06.026. PubMed PMID: 26122764.
   PubMed Web of Science ®Google Scholar
• Frazzoni M, Manta R, Mirante VG, et al. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease–a 24-h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013 May;25(5):399–406, e295. doi: 10.1111/nmo.12080. PubMed PMID: 23360178.
   PubMed Web of Science ®Google Scholar
• Martinucci I, de Bortoli N, Savarino E, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014 Apr;26(4):546–555. doi: 10.1111/nmo.12299. PubMed PMID: 24433456.
   PubMed Web of Science ®Google Scholar
• Hoshikawa Y, Sawada A, Sonmez S, et al. Measurement of esophageal nocturnal baseline impedance: a simplified method. J Neurogastroenterol Motil. 2020 Apr 30;26(2):241–247. doi: 10.5056/jnm19183. PubMed PMID: 32235031; PubMed Central PMCID: PMCPMC7176501.
   PubMed Web of Science ®Google Scholar
• Frazzoni M, de Bortoli N, Frazzoni L, et al. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring. Neurogastroenterol Motil. 2017 Sep 12;29(3). doi: 10.1111/nmo.12947. PubMed PMID: 27620303.
   Web of Science ®Google Scholar
• Frazzoni L, Frazzoni M, de Bortoli N, et al. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time. Neurogastroenterol Motil. 2017 Nov;29(11). doi: 10.1111/nmo.13116. PubMed PMID: 28543861.
   Web of Science ®Google Scholar
• Patel A, Sayuk GS, Gyawali CP. Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters. Am J Gastroenterol. 2014 Jun;109(6):836–844. doi: 10.1038/ajg.2014.63. PubMed PMID: 24732868; PubMed Central PMCID: PMCPMC4104528.
   PubMed Web of Science ®Google Scholar
• Zerbib F, Belhocine K, Simon M, et al. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut. 2012 Apr;61(4):501–506. doi: 10.1136/gutjnl-2011-300798. PubMed PMID: 21997546.
   PubMed Web of Science ®Google Scholar
• Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018 Jul;67(7):1351–1362. doi: 10.1136/gutjnl-2017-314722. PubMed PMID: 29437910; PubMed Central PMCID: PMCPMC6031267.
   PubMed Web of Science ®Google Scholar
• Gyawali CP, Tutuian R, Zerbib F, et al. Value of pH Impedance monitoring while on twice-daily proton pump inhibitor therapy to identify need for escalation of reflux management. Gastroenterology. 2021 Nov;161(5):1412–1422. doi: 10.1053/j.gastro.2021.07.004. PubMed PMID: 34270955.
   PubMed Web of Science ®Google Scholar
• Chae S, Richter JE. Wireless 24, 48, and 96 hour or impedance or oropharyngeal prolonged pH Monitoring: which test, when, and why for GERD? Curr Gastroenterol Rep. 2018 Sep 26;20(11):52. doi: 10.1007/s11894-018-0659-0. PubMed PMID: 30259210.
   PubMedGoogle Scholar
• Chotiprashidi P, Liu J, Carpenter S, et al. ASGE technology status evaluation report: wireless esophageal pH monitoring system. Gastrointest Endosc. 2005 Oct;62(4):485–487. doi: 10.1016/j.gie.2005.07.007. PubMed PMID: 16185957.
   PubMed Web of Science ®Google Scholar
• Ang D, Teo EK, Ang TL, et al. To bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort. J of Digest Dis. 2010 Feb;11(1):19–27. doi: 10.1111/j.1751-2980.2009.00409.x. PubMed PMID: 20132427.
   PubMed Web of Science ®Google Scholar
• Yadlapati R, Gyawali CP, Masihi M, et al. Optimal wireless reflux monitoring metrics to predict discontinuation of proton pump inhibitor therapy. Am J Gastroenterol. 2022 Oct 1;117(10):1573–1582. doi: 10.14309/ajg.0000000000001871. PubMed PMID: 35973148; PubMed Central PMCID: PMCPMC9532366.
   PubMed Web of Science ®Google Scholar
• Giuseppe S, Galante P, Manganaro M, et al. Evaluation of 96-hour pH Monitoring with the bravo wireless system in 60 patients. Gastrointest Endosc. 2006;63(5):AB126. doi: 10.1016/j.gie.2006.03.194
   Web of Science ®Google Scholar
• Shah ED, Chan WW, Jodorkovsky D, et al. Optimizing the management algorithm for heartburn in general gastroenterology: cost-effectiveness and cost-minimization analysis. Clin Gastroenterol Hepatol. 2023 Sep 7. doi: 10.1016/j.cgh.2023.08.026. PubMed PMID: 37683879.
   Google Scholar
• Bautista JM, Wong WM, Pulliam G, et al. The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications. Dig Dis Sci. 2005 Oct;50(10):1909–1915. doi: 10.1007/s10620-005-2960-7. PubMed PMID: 16187196.
   PubMed Web of Science ®Google Scholar
• Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001 Jun;120(7):1599–1606. doi: 10.1053/gast.2001.24840. PubMed PMID: 11375942.
   PubMed Web of Science ®Google Scholar
• Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2011 Oct;9(10):868–874. doi: 10.1016/j.cgh.2011.07.009. PubMed PMID: 21782769.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Hunter JG, Jones KM, et al. Randomized trial of medical versus surgical treatment for refractory heartburn. N Engl J Med. 2019 Oct 17;381(16):1513–1523. doi: 10.1056/NEJMoa1811424. PubMed PMID: 31618539.
   PubMed Web of Science ®Google Scholar
• Patel DA, Naik R, Slaughter JC, et al. Weight loss in achalasia is determined by its phenotype. Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy046. PubMed PMID: 29788157.
   Web of Science ®Google Scholar
• Patel DA, Yadlapati R, Vaezi MF. Esophageal motility disorders: current approach to diagnostics and therapeutics. Gastroenterology. 2022 May;162(6):1617–1634. doi: 10.1053/j.gastro.2021.12.289. PubMed PMID: 35227779.
   PubMed Web of Science ®Google Scholar
• Werner YB, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019 Dec 5;381(23):2219–2229. doi: 10.1056/NEJMoa1905380. PubMed PMID: 31800987.
   PubMed Web of Science ®Google Scholar
• Ponds FA, Oors JM, Smout A, et al. Reflux symptoms and oesophageal acidification in treated achalasia patients are often not reflux related. Gut. 2021 Jan;70(1):30–39. doi: 10.1136/gutjnl-2020-320772. PubMed PMID: 32439713; PubMed Central PMCID: PMCPMC7788183.
   PubMed Web of Science ®Google Scholar
• Singh AP, Singla N, Budhwani E, et al. Defining the “true acid reflux” after per-oral endoscopic myotomy for achalasia: a prospective cohort study. Gastrointest Endosc. 2023 Aug 18. doi: 10.1016/j.gie.2023.08.008. PubMed PMID: 37598862.
   Google Scholar
• Katzka DA, Ravi K, Geno DM, et al. Endoscopic mucosal impedance measurements correlate with eosinophilia and dilation of intercellular spaces in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015 Jul;13(7):1242–1248.e1. doi: 10.1016/j.cgh.2014.12.032. PubMed PMID: 25592662.
   PubMed Web of Science ®Google Scholar
• Choksi Y, Lal P, Slaughter JC, et al. Esophageal mucosal impedance patterns discriminate patients with eosinophilic esophagitis from patients with GERD. Clin Gastroenterol Hepatol. 2018 May;16(5):664–671.e1. doi: 10.1016/j.cgh.2017.12.020. PubMed PMID: 29248733.
   PubMed Web of Science ®Google Scholar
• Yadlapati R, Gyawali CP, Pandolfino JE, et al. AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol. 2022 May;20(5):984–994.e1. doi: 10.1016/j.cgh.2022.01.025. PubMed PMID: 35123084; PubMed Central PMCID: PMCPMC9838103.
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Fass R. Reflux Hypersensitivity: A New Functional Esophageal Disorder. J Neurogastroenterol Motil. 2017 Oct 30;23(4):495–503. 10.5056/jnm17097. PubMed PMID: 28992673; PubMed Central PMCID: PMCPMC5628981.
   PubMed Web of Science ®Google Scholar
• Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006 Oct;55(10):1398–1402. doi: 10.1136/gut.2005.087668. PubMed PMID: 16556669; PubMed Central PMCID: PMCPMC1856433.
   PubMed Web of Science ®Google Scholar